Danish study finds most meningioma surveillance MRIs do not change management
A nationwide Danish quality improvement study analyzed 8,134 adults diagnosed with meningioma between 2010 and 2023, tracking incidence, treatment rates, and surveillance imaging. The study reported that age- and sex-standardized incidence nearly doubled over the period (6.4 to 12.6 per 100,000 person-years), while yearly treatment rates remained stable; 65.2% of patients received no treatment. Of 28,736 follow-up MRI scans performed, 83.5% were not followed by treatment, and only 1.4% of patients underwent surgery after year 5, leading the authors to suggest that a substantial proportion of follow-up imaging could be reduced within a risk-adapted framework.
Most relevant for: Adults with meningioma who are undergoing surveillance imaging without planned initial treatment
Read the original at JAMA OncologySummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More oncology updates
- ASCO updates living guideline on advanced biliary tract cancer careOct 14, 2026
- Hypofractionated PMRT Noninferior to Conventional in Reconstruction PatientsOct 12, 2026
- Tomosynthesis screening shows lower interval cancer rate than mammographyOct 9, 2026
- Metastasis-directed ablation fails to improve PFS in oligometastatic breast cancer trialOct 7, 2026
- Updated pediatric guideline on antibacterial and antifungal prophylaxis in cancerOct 2, 2026